These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 38346390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions?
    Bapat P, Paul S, Thakral NK, Tseng YC, Taylor LS.
    Mol Pharm; 2023 Nov 06; 20(11):5714-5727. PubMed ID: 37751517
    [Abstract] [Full Text] [Related]

  • 3. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide.
    Zhang HJ, Chiang CW, Maschmeyer-Tombs T, Conklin B, Napolitano JG, Lubach JW, Nagapudi K, Mao C, Chen Y.
    Mol Pharm; 2024 Jul 01; 21(7):3395-3406. PubMed ID: 38836777
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R, Mann AKP, Van Duong T, Ormes JD, Okoh GA, Hermans A, Taylor LS.
    Mol Pharm; 2021 May 03; 18(5):2066-2081. PubMed ID: 33784104
    [Abstract] [Full Text] [Related]

  • 6. Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel.
    Polyzois H, Nguyen HT, Roberto de Alvarenga Junior B, Taylor LS.
    Mol Pharm; 2024 Oct 07; 21(10):5285-5296. PubMed ID: 39292641
    [Abstract] [Full Text] [Related]

  • 7. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
    Nunes PD, Pinto JF, Henriques J, Paiva AM.
    Mol Pharm; 2022 Jan 03; 19(1):51-66. PubMed ID: 34919407
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.
    Nguyen HT, Van Duong T, Jaw-Tsai S, Bruning-Barry R, Pande P, Taneja R, Taylor LS.
    Mol Pharm; 2023 Jun 05; 20(6):3170-3186. PubMed ID: 37220082
    [Abstract] [Full Text] [Related]

  • 10. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
    Solanki NG, Lam K, Tahsin M, Gumaste SG, Shah AV, Serajuddin ATM.
    J Pharm Sci; 2019 Apr 05; 108(4):1453-1465. PubMed ID: 30395834
    [Abstract] [Full Text] [Related]

  • 11. Impact of Gastric pH Variations on the Release of Amorphous Solid Dispersion Formulations Containing a Weakly Basic Drug and Enteric Polymers.
    Nguyen HT, Van Duong T, Taylor LS.
    Mol Pharm; 2023 Mar 06; 20(3):1681-1695. PubMed ID: 36730186
    [Abstract] [Full Text] [Related]

  • 12. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS, Lou X, Zhang GGZ, Taylor LS.
    Mol Pharm; 2019 Mar 04; 16(3):1327-1339. PubMed ID: 30669846
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. pH-Dependent supersaturation from amorphous solid dispersions of weakly basic drugs.
    Wang B, Nethercott MJ, Narula A, Hanrahan M, Kuang S, Wenslow RM, Li N.
    Pharm Res; 2022 Nov 04; 39(11):2919-2936. PubMed ID: 34890018
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comprehensive evaluation of polymer types and ratios in Spray-Dried Dispersions: Compaction, Dissolution, and physical stability.
    Yu D, Nie H, Hoag SW.
    Int J Pharm; 2024 Jan 25; 650():123674. PubMed ID: 38061497
    [Abstract] [Full Text] [Related]

  • 17. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T, Taylor LS.
    Mol Pharm; 2016 Mar 07; 13(3):873-84. PubMed ID: 26791934
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
    Zhang S, Lee TWY, Chow AHL.
    Int J Pharm; 2019 Jan 30; 555():394-403. PubMed ID: 30513399
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.